Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acton, 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science, 271, 518, 10.1126/science.271.5248.518
Boehm, 1995, Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells, J. Med. Chem., 38, 3146, 10.1021/jm00016a018
Brown, 1983, Lipoprotein metabolism in the macrophage, Annu. Rev. Biochem., 52, 223, 10.1146/annurev.bi.52.070183.001255
Buja, 1983, Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia, Arteriosclerosis, 3, 87, 10.1161/01.ATV.3.1.87
Chawla, 1994, Peroxisome proliferator-activated receptor (PPAR) γ, Endocrinology, 135, 798, 10.1210/endo.135.2.8033830
Endemann, 1993, CD36 is a receptor for oxidized low density lipoprotein, J. Biol. Chem., 268, 11811, 10.1016/S0021-9258(19)50272-1
Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939
Folcik, 1995, Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques, J. Clin. Invest., 96, 504, 10.1172/JCI118062
Fong, 1991, Inhibition of lipopolysaccharide induced IL-1β mRNA expression in mouse macrophages by oxidized low density lipoprotein, J. Lipid Res., 32, 1899, 10.1016/S0022-2275(20)41893-0
Forman, 1995, 15-deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ, Cell, 83, 803, 10.1016/0092-8674(95)90193-0
Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ, Proc. Natl. Acad. Sci. USA, 94, 4312, 10.1073/pnas.94.9.4312
Glavind, 1952, Studies on the role of lopoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta, APMIS (Copenhagen), 30, 1
Goldstein, 1974, Binding and degradation of low density lipoprotein by cultured human fibroblasts, J. Biol. Chem., 249, 5154, 10.1016/S0021-9258(19)42341-7
Goldstein, 1977, The low-density lipoprotein pathway and its relation to atherosclerosis, Annu. Rev. Biochem., 46, 897, 10.1146/annurev.bi.46.070177.004341
Goldstein, 1979, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition, Proc. Natl. Acad. Sci. USA, 76, 333, 10.1073/pnas.76.1.333
Hamilton, 1990, Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages, J. Immunol., 144, 2343
Hamilton, 1995, The effects of oxidized low density lipoprotein on inducible mouse macrophage gene expression are gene and stimulus dependent, J. Clin. Invest., 95, 2020, 10.1172/JCI117887
Han, 1997, Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36, J. Biol. Chem., 272, 21654, 10.1074/jbc.272.34.21654
Huang, 1991, Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn and Yes protein-tyrosine kinases in human platelets, Proc. Natl. Acad. Sci. USA, 88, 7844, 10.1073/pnas.88.17.7844
Huh, 1996, Regulated expression of CD36 during monocyte-to-macrophage differentiation, Blood, 87, 2020, 10.1182/blood.V87.5.2020.2020
Jiang, 1998, PPARγ agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/35154
Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors, Nature, 358, 771, 10.1038/358771a0
Kliewer, 1995, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation, Cell, 83, 813, 10.1016/0092-8674(95)90194-9
Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ, Proc. Natl. Acad. Sci. USA, 94, 4318, 10.1073/pnas.94.9.4318
Ku, 1992, Induction of interleukin 1β expression from human peritoneal blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid, J. Biol. Chem., 267, 14183, 10.1016/S0021-9258(19)49695-6
Kuhn, 1994, Involvement of 15-lipoxygenase in early stages of atherogenesis, J. Exp. Med., 179, 1903, 10.1084/jem.179.6.1903
Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ), J. Biol. Chem., 270, 12953, 10.1074/jbc.270.22.12953
Lehr, 1993, Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex, Lab. Invest., 68, 388
Lenz, 1990, Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein, J. Lipid Res., 31, 1043, 10.1016/S0022-2275(20)42744-0
Lipton, 1995, Components of the protein fraction of oxidized low density lipoprotein stimulates interleukin-1α production by rabbit arterial macrophage-derived foam cells, J. Lipid Res., 36, 2232, 10.1016/S0022-2275(20)39207-5
Malden, 1991, The influence of oxidatively modified LDL on expression of platelet derived growth factor by human monocyte-derived macrophages, J. Biol. Chem., 266, 13901, 10.1016/S0021-9258(18)92786-9
Matsumoto, 1990, Human macrophage scavenger receptors, Proc. Natl. Acad. Sci. USA, 87, 9133, 10.1073/pnas.87.23.9133
Nozaki, 1995, Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects, J. Clin. Invest., 96, 1859, 10.1172/JCI118231
Ohlsson, 1996, Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages, J. Clin. Invest., 98, 78, 10.1172/JCI118780
Quinn, 1987, Oxidatively modified low density lipoproteins, Proc. Natl. Acad. Sci. USA, 84, 2995, 10.1073/pnas.84.9.2995
Ricote, 1998, The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation, Nature, 391, 79, 10.1038/34178
Simon, 1989, Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe heritable hyperlipidemic and cholesterol-fed rabbits, Atherosclerosis, 75, 31, 10.1016/0021-9150(89)90204-9
Steinberg, 1997, Low density lipoprotein oxidation and its pathobiological significance, J. Biol. Chem., 272, 20963, 10.1074/jbc.272.34.20963
Steinbrecher, 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl. Acad. Sci. USA, 81, 3883, 10.1073/pnas.81.12.3883
Suzuki, 1997, A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection, Nature, 386, 292, 10.1038/386292a0
Thomas, 1991, Lipid hydroperoxyde involvement in copper-dependent and independent oxidation of low density lipoproteins, J. Pharmacol. Exp. Ther., 256, 1182
Thomas, 1994, Multiple lipid oxidation products in low density lipoproteins induce interleukin-1β release from human blood mononuclear cells, J. Lipid Res., 35, 417, 10.1016/S0022-2275(20)41193-9
Tontonoz, 1994, Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor, Cell, 79, 1147, 10.1016/0092-8674(94)90006-X
Tontonoz, 1998, PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL, Cell, 93, 241, 10.1016/S0092-8674(00)81575-5